Accelerating Innovative Solutions
MicrosensDx is a dynamic and ambitious innovator at the leading edge of the diagnostics sector for more than 20 years.
Our vision is to build a global brand delivering innovative diagnostic solutions which transform patient outcomes.
Our dedicated team is aligned to our mission of building a global brand, delivering sample to result molecular solutions, transforming patient outcomes with fast accurate diagnosis.
Headquartered in Cambridge, close to one of the UK’s most dynamic life science clusters, MicrosensDx, is driven by the science of innovation.
We have been in business for over 20 years and hold over 18 different pieces of IP.
We focus on the thoroughness of the science to ensure we get it right the first time.
Our scientists are accessible to our customers, not hidden behind layers of bureaucracy.
We are test agnostic. We are not wedded to one solution, we are market leading experts in LAMP and PCR. We want the best clinical outcome.
Our customers are always front of mind. Everything we do through innovation to product delivery is driven by our passion for positive patient outcomes.
We focus on developing diagnostics for pathogens, including Coronavirus, Tuberculosis, Flu, RSV, Norovirus and protein aggregation diseases such as Alzheimer’s, Parkinson’s and prion diseases. We are constantly investing and innovating to deliver best-in-class speed and accuracy for our customers, across all available platforms, including LAMP and PCR.
Our proprietary RapiPRO™ Loop-mediated Isothermal Amplification (LAMP) test is clinically validated to run on multiple platforms to detect SARS-CoV-2.
Our management team has demonstrable expertise in developing and commercialising diagnostics, building and protecting patent portfolios, and scaling successful businesses.
Dr Mark Street-Docherty
Chief Executive Officer
An entrepreneurial and dynamic executive with a strong track record of success in the life sciences sector, Mark joined MicrosensDx, as CEO in September 2020 to lead the business through an accelerated growth phase.
In his previous role as CEO of Elucigene Diagnostics, he led a successful trade sale to Yourgene Health plc, having overseen rapid revenue growth following implementing of a successful internationalisation strategy which saw products sold in more than 55 markets globally.
Mark has a Ph.D. in Molecular Immunology and Mammalian Cell Biology from the University of Sheffield and a MBA from Leeds Beckett University. Outside work he is a very keen baker and also loves travelling.
Dr Stuart Wilson
Chief Scientific Officer
A serial life sciences entrepreneur Stuart co-founded MicrosensDx in 2000 to develop detection methods for the prion disease BSE and the human form vCJD.
He has also co-founded three other life science companies focusing on sepsis, therapeutics for neurodegenerative diseases and rapid infectious disease testing for blood-borne pathogens.
In his previous role as Deputy Director of the National TB Reference Laboratory he set up the national testing service for tuberculosis in the UK.
Sales and marketing specialist Patrick joined the MicrosensDx team in late 2020 with more than 15 years’ experience in the biotech, diagnostics & health and wellbeing markets.
Currently overseeing the company’s rebrand and implementing its growth strategy, Patrick has a proven track record in Operations, Business Development, and Sales and Marketing. His previous role saw him spend more than eight years with Omega Diagnostics, rising to Director of Marketing.
He holds an MBA from the University of Liverpool, having graduated in Biological Sciences from Manchester Metropolitan University. Outside of work he enjoys golf, travelling and most recently photography.
Quality Assurance and Regulatory Affairs Manager
Mike joined the MicrosenDx team in November 2020 bringing more than 40 years’ experience in the diagnostics sector.
His expertise has been gained across a number of disciplines including Quality, Regulatory, Operations, Project Management and Research & Development.
Previous employers have included Unilever, Siemens and Alere as well as other SMEs. Notably, whilst with Alere he oversaw the production of more than 90 million OTC products.
Beyond work Mike is a trustee for the charity Action for Aspergers and is a passionate car owner, with his pride and joy being a 17-year-old Subaru Impreza, a Japanese import in sonic blue with gold alloy wheels.